Glenmark Generics, USA, the subsidiary of Glenmark Pharmaceuticals, has been granted final approval from the United States Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluocinonide Cream USP 0.1%, the generic version of Vanos Cream by Medicis.

Fluocinonide Cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

According to IMS Health sales data for the 12 month period ending March 2014, Fluocinonide Cream garnered annual sales of approximately USD 103 million.

Shares of the company gained Rs 12.95, or 2.40%, to trade at Rs 552.10 at the BSE (10.30 a.m., Tuesday).